Patients’ persistent symptoms, clinician demographics and geo-economic factors are associated with choice of therapy for hypothyroidism by European thyroid specialists: The “THESIS”* collaboration (*Treatment of Hypothyroidism in Europe by Specialists, an International Survey)
Authors:
- Roberto AttanasioRARoberto Attanasio
- Miloš ŽarkovićMŽMiloš Žarković
- Enrico PapiniEPEnrico Papini
- Endre V. NagyENEndre V. Nagy
- Roberto NegroRNRoberto Negro
- Petros PerrosPPPetros Perros
- Ersin AkarsuEAErsin Akarsu
- Maria AlevizakiMAMaria Alevizaki
- Göksun AyvazGAGöksun Ayvaz
- Tomasz BednarczukTBTomasz Bednarczuk
- Biljana BeleslinBBBiljana Beleslin
- Eszter BertaEBEszter Berta
- 18 February 2024
- journal article
- research article
- Published by SAGE Publications in Thyroid®
- Vol. 34 (4) , 429-441
Abstract
Background. Hypothyroidism is common, however, aspects of its treatment remain controversial. Our survey aimed at documenting treatment choices of European thyroid specialists and exploring how patients’ persistent symptoms, clinician demographics, and geo-economic factors relate to treatment choices. Methods. 17,247 thyroid specialists from 28 countries were invited to participate in an online questionnaire survey. The survey included respondent demographic data and treatment choices for hypothyroid patients with persistent symptoms. Geo-economic data for each country were included in the analyses. Results. The response rate was 32.9% (6,058 respondents out of 17,247 invitees). Levothyroxine (LT4) was the initial treatment preferred by the majority (98.3%). Persistent symptoms despite normal serum thyrotropin (TSH) while receiving LT4 treatment were reported to affect up to 10.0% of patients by 75.4% of respondents, while 28.4% reported an increasing such trend in the past five years. The principal explanations offered for patients’ persistent symptoms were psychosocial factors (77.1%), comorbidities (69.2%), and unrealistic patient expectations (61.0%). Combination treatment with LT4 + liothyronine (LT3) was chosen by 40.0% of respondents for patients who complained of persistent symptoms despite a normal TSH. This option was selected more frequently by female thyroid specialists, with high-volume practice, working in countries with high gross national income per capita. Conclusions. The perception of patients’ dissatisfaction reported by physicians seems lower than that described by hypothyroid patients in previous surveys. LT4+LT3 treatment is used frequently by thyroid specialists in Europe for persistent hypothyroid-like symptoms even if they generally attribute such symptoms to non-endocrine causes and despite the evidence of non-superiority of the combined over the LT4 therapy. Pressure by dissatisfied patients on their physicians for LT3-containing treatments is a likely explanation. The association of the therapeutic choices with the clinician demographic characteristics and geo-economic factors in Europe is a novel information and requires further investigation.Keywords
This publication has 46 references indexed in Scilit:
- Observational study of diagnosis and management in adult primary hypothyroidism in southwest of SwedenScandinavian Journal of Primary Health Care, 2023
- A Questionnaire Survey of German Thyroidologists on the Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients: The THESIS (Treatment of Hypothyroidism in Europe by Specialists: An International Survey) CollaborativeExperimental and Clinical Endocrinology & Diabetes, 2022
- The relevance of T3 in the management of hypothyroidismThe Lancet Diabetes & Endocrinology, 2022
- Real-life practice of thyroid hormone use in hypothyroid and euthyroid patients: A detailed view from the THESIS questionnaire survey in FranceAnnales d'Endocrinologie, 2022
- Use of thyroid hormones in hypothyroid and euthyroid patients: a 2020 THESIS questionnaire survey of members of the Hellenic Endocrine Society.Hormones, 2021
- Levothyroxine Use in the United States, 2008-2018JAMA Internal Medicine, 2021
- Use of thyroid hormones in hypothyroid and euthyroid patients: A 2020 THESIS questionnaire survey of members of the Danish Endocrine SocietyJournal of Endocrinological Investigation, 2021
- Diagnóstico y tratamiento del nódulo tiroideo en España. Resultados de una encuesta nacionalEndocrinología, Diabetes y Nutrición, 2020
- Global epidemiology of hyperthyroidism and hypothyroidismNature Reviews Endocrinology, 2018
- Falling Threshold for Treatment of Borderline Elevated Thyrotropin Levels—Balancing Benefits and RisksJAMA Internal Medicine, 2014